These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28283988)

  • 1. Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis.
    Marchand M; Brossard P; Merdjan H; Lama N; Weitkunat R; Lüdicke F
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):943-954. PubMed ID: 28283988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
    Olsson Gisleskog PO; Perez Ruixo JJ; Westin Å; Hansson AC; Soons PA
    Clin Pharmacokinet; 2021 Apr; 60(4):541-561. PubMed ID: 33354734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.
    Brossard P; Weitkunat R; Poux V; Lama N; Haziza C; Picavet P; Baker G; Lüdicke F
    Regul Toxicol Pharmacol; 2017 Oct; 89():193-199. PubMed ID: 28760390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
    Kraiczi H; Hansson A; Perfekt R
    Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic investigation of a nicotine sublingual tablet.
    Molander L; Lunell E
    Eur J Clin Pharmacol; 2001; 56(11):813-9. PubMed ID: 11294371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
    Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes.
    Picavet P; Haziza C; Lama N; Weitkunat R; Lüdicke F
    Nicotine Tob Res; 2016 May; 18(5):557-63. PubMed ID: 26438645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of nicotine applied to different nasal regions.
    Johansson CJ; Olsson P; Bende M; Carlsson T; Gunnarsson PO
    Eur J Clin Pharmacol; 1991; 41(6):585-8. PubMed ID: 1815971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
    Caldwell B; Burgess C; Crane J
    Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
    Schneider NG; Lunell E; Olmstead RE; Fagerström KO
    Clin Pharmacokinet; 1996 Jul; 31(1):65-80. PubMed ID: 8827400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.
    Walele T; Sharma G; Savioz R; Martin C; Williams J
    Regul Toxicol Pharmacol; 2016 Feb; 74():187-92. PubMed ID: 26696273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.
    Stiles MF; Campbell LR; Graff DW; Jones BA; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2017 Sep; 234(17):2643-2655. PubMed ID: 28634710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable isotope studies of nicotine kinetics and bioavailability.
    Benowitz NL; Jacob P; Denaro C; Jenkins R
    Clin Pharmacol Ther; 1991 Mar; 49(3):270-7. PubMed ID: 2007322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function.
    Fishbein L; O'Brien P; Hutson A; Theriaque D; Stacpoole PW; Flotte T
    J Investig Med; 2000 Nov; 48(6):435-40. PubMed ID: 11094866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial/venous plasma nicotine concentrations following nicotine nasal spray.
    Guthrie SK; Zubieta JK; Ohl L; Ni L; Koeppe RA; Minoshima S; Domino EF
    Eur J Clin Pharmacol; 1999 Nov; 55(9):639-43. PubMed ID: 10638392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
    Marsh HS; Dresler CM; Choi JH; Targett DA; Gamble ML; Strahs KR
    Clin Ther; 2005 Oct; 27(10):1571-87. PubMed ID: 16330293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.